RecruitingNot ApplicableNCT06679569

Deep Neuromuscular Blockade on Postoperative Pain

Effect of Deep Neuromuscular Blockade on Postoperative Pain in Pediatric Patients Undergoing Laparoscopic Surgery: a Prospective Randomized Controlled Trial


Sponsor

Seoul National University Hospital

Enrollment

106 participants

Start Date

Nov 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the impact of varying degrees of neuromuscular blockade on postoperative pain in pediatric patients aged over 2 months to under 7 years undergoing laparoscopic surgery under general anesthesia.


Eligibility

Min Age: 2 MonthsMax Age: 7 Years

Inclusion Criteria2

  • Pediatric patients aged over 2 months to under 7 years scheduled for laparoscopic surgery under general anesthesia.
  • American Society of Anesthesiologists (ASA) Physical Status Classification I, II, or III.

Exclusion Criteria6

  • Patients undergoing emergency surgery.
  • Patients with chronic pain or currently taking analgesics for chronic pain.
  • Known hypersensitivity to general anesthetic agents or analgesics.
  • Patients with underlying cardiovascular disease.
  • Patients with neuromuscular disorders.
  • Any other condition that, in the investigator's judgment, would make the patient unsuitable for participation in the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGrocuronium 0.2 mg/kg/hr continuous infusion

To maintain Train-of-four count 1 to 3 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.2 mg/kg/hr to achieve and sustain moderate neuromuscular blockade.

DRUGrocuronium 0.6 mg/kg/hr continuous infusion

To maintain Train-of-four count 0 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.6 mg/kg/hr to achieve and sustain deep neuromuscular blockade.


Locations(1)

SNUCH

Seoul, Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06679569


Related Trials